Freshfields advises Novartis on US$13bn sale of stake in consumer health JV to partner GlaxoSmithKline plcFreshfields Bruckhaus Deringer (‘Freshfields’) has advised Novartis AG on the sale of its 36.5% stake in its consumer health joint venture with GlaxoSmithKline plc for US$13bn. Details of the transaction can be found here.
The Freshfields team was led by Julian Long and Jennifer Bethlehem with tax partner Paul Davison and antitrust partner Rod Carlton.
Notes for editors
About Freshfields Bruckhaus Deringer
Freshfields Bruckhaus Deringer LLP is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on ground-breaking and business-critical mandates. Our 2,800 plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multi-national expertise and business know-how means our clients rely on us when it matters most.